文献速递主动脉疾病外周动脉疾病

髂动脉分支装置腔内治疗髂总动脉瘤:140例多中心经验

Endovascular Treatment of Common Iliac Artery Aneurysms With an Iliac Branch Device: Multicenter Experience of 140 Patients.
PubMed 文献 · J Endovasc Ther · 2016-11-19

荷兰7中心回顾性分析140例患者162次Zenith ZBIS髂动脉分支装置(IBD)植入,技术成功率96.9%,随访26.6个月,IBD相关二次干预率12.1%,5年免于二次干预率75.9%。结论认为IBD可安全有效治疗髂总动脉瘤并保留髂内动脉前向血流。

要点

  • IBD治疗髂总动脉瘤技术成功率达96.9%,可保留髂内动脉前向血流。
  • 随访期间12.1%患者需IBD相关二次干预,多数可腔内完成。
  • 5年免于二次干预率为75.9%(95%CI 59.7–86.3)。

核心结论

  • 髂动脉分支装置可安全有效地治疗髂总动脉瘤,并保留髂内动脉前向血流。
  • 随访期间超过10%患者需二次干预,但多数可经腔内完成。

研究设计与样本

  • 荷兰7个血管中心回顾性多中心队列,纳入2004年9月至2015年8月140例患者(平均年龄70.9±7.4岁,130例男性),共162次Zenith ZBIS IBD植入。
  • IBD植入指征包括腹主动脉瘤>55 mm伴髂总动脉瘤>20 mm(n=40)、髂总动脉瘤直径>30 mm(n=89)或EVAR后Ib型内漏翻修(n=11)。

主要发现

  • 技术成功(动脉瘤隔绝、无I或III型内漏、髂内动脉通畅)157/162次(96.9%)。
  • 6例(4.3%)发生重大并发症,2例(1.4%)死亡。
  • 平均随访26.6±24.1个月,17例(12.1%)接受IBD相关二次干预。
  • 包括技术失败和有意髂内动脉栓塞,共识别15例(9.3%)髂内动脉分支闭塞,其中6例出现臀部跛行。
  • 5年免于二次干预估计值为75.9%(95%CI 59.7–86.3)。

临床怎么用

  • 对合并髂总动脉瘤的腹主动脉瘤患者,可考虑使用IBD保留髂内动脉前向血流。
  • 术后随访需关注髂内动脉分支闭塞及二次干预风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the efficacy, feasibility, and long-term outcomes of the Zenith ZBIS iliac branch device (IBD) to preserve internal iliac artery (IIA) perfusion in a large Dutch multicenter cohort. METHODS: Between September 2004 and August 2015, 140 patients (mean age 70.9±7.4 years; 130 men) with 162 IBD implantations were identified in 7 vascular centers. The indication for IBD implantation was an abdominal aortic aneurysm >55 mm with a concomitant common iliac artery (CIA) aneurysm >20 mm (n=40), a CIA aneurysm with a diameter >30 mm (n=89), or revision of a type Ib endoleak after endovascular aneurysm repair (n=11). RESULTS: Technical success (aneurysm exclusion, no type I or III endoleak, and a patent IIA) was obtained in 157 (96.9%) of 162 IBD implantations. Six (4.3%) patients developed major complications; 2 (1.4%) died. Mean follow-up was 26.6±24.1 months, during which 17 (12.1%) IBD-associated secondary interventions were performed. Including technical failures and intentional IIA embolizations, 15 (9.3%) IIA branch occlusions were identified; buttock claudication developed in 6 of these patients. The freedom from secondary intervention estimate was 75.9% (95% confidence interval 59.7 to 86.3) at 5 years. CONCLUSION: CIA aneurysms can be treated safely and effectively by IBDs with preservation of antegrade flow to the IIA. Secondary interventions are indicated in >10% of patients during follow-up but can be performed endovascularly in most.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Jongsma H, Bekken JA, Bekkers WJ, et al. Endovascular Treatment of Common Iliac Artery Aneurysms With an Iliac Branch Device: Multicenter Experience of 140 Patients. J Endovasc Ther. 2016. PMID: 27864456. doi:10.1177/1526602816679132

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。